uza-cel

Galapagos selects Adaptimmune T-cell therapy for $665M biobucks collab
Fierce Biotech
Fri, 05/31/24 - 10:52 am
Galapagos
Adaptimmune
biobucks
t-cell therapies
uza-cel
ovarian cancer